Viking Therapeutics (VKTX) is currently testing the bottom of a key daily gap near the $30 level, an area that has acted as strong technical support and a potential reversal zone. A confirmed breakout above the $43 level would signal renewed bullish momentum and open the door for a move toward the $62.18 resistance, which aligns with prior highs and major supply levels.
This setup offers a great risk-to-reward ratio, with a clearly defined stop loss at $22.26, allowing downside risk to be managed while targeting substantial upside.
From a fundamental standpoint, VKTX continues to attract attention in the biotech space due to its obesity and metabolic disease pipeline, which has kept institutional interest elevated and volatility high—an ideal environment for momentum-driven moves once key levels break.
This setup offers a great risk-to-reward ratio, with a clearly defined stop loss at $22.26, allowing downside risk to be managed while targeting substantial upside.
From a fundamental standpoint, VKTX continues to attract attention in the biotech space due to its obesity and metabolic disease pipeline, which has kept institutional interest elevated and volatility high—an ideal environment for momentum-driven moves once key levels break.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.